Skip to main content

BSI Proteomics to Determine Structure of CF Membrane Protein

NEW YORK, March 21 (GenomeWeb News) - BSI Proteomics said last week that it will perform protein crystallization and structure determination services for the Cystic Fibrosis Foundation.

 

The foundation selected BSI to express, purify, crystallize, and determine the structure of the cystic fibrosis trans-conductance protein, a membrane protein that has proved difficult to purify, according to the Gaithersburg, MD.-based firm.

 

BSI will use its Membrane Protein Stabilization System, which has particular capabilities for stabilizing membrane, ion-channel, and other "difficult" soluble proteins, the company said. BSI claims that its technology can produce diffractable crystals in months, compared to years required for other methods.

 

The company did not disclose any financial terms for its agreement with the Cystic Fibrosis Foundation.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.